Mark Aleynick
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- interferon and immune responses
- Immune cells in cancer
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 3
-
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 2
- Co-authors
- Judit Svensson‐Arvelund (4 shared papers)Joshua Brody (5 shared papers)Aurélien Marabelle (1 shared paper)Christopher R. Flowers (1 shared paper)Miriam Mérad (3 shared papers)Brian D. Brown (4 shared papers)Ranjan Upadhyay (4 shared papers)Linda Hammerich (3 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)Clinical Cancer Research (1 paper)Cancer Discovery (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Mark Aleynick
5 papers receiving 104 citations
Peers
Comparison fields: 5 of 27
- Immunology 73
- Oncology 51
- Biotechnology 8
- Genetics 19
- Hematology 5
Countries citing papers authored by Mark Aleynick
This map shows the geographic impact of Mark Aleynick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Aleynick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Aleynick more than expected).
Fields of papers citing papers by Mark Aleynick
This network shows the impact of papers produced by Mark Aleynick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Aleynick. The network helps show where Mark Aleynick may publish in the future.
Co-authors
The 18 scholars most cited alongside Mark Aleynick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 45 | |
| 2 | 2019 | 44 | |
| 3 | 2019 | 13 | |
| 4 | 2023 | 3 | |
| 5 | 2018 | 1 |
About Mark Aleynick
Mark Aleynick is a scholar working on Oncology, Immunology, Genetics, Infectious Diseases and Organic Chemistry, having authored 5 papers that have together received 106 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (2 papers) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Immunology (73 citations), Oncology (51 citations), Biotechnology (8 citations), Genetics (19 citations) and Hematology (5 citations). Mark Aleynick has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Judit Svensson‐Arvelund, Joshua Brody, Aurélien Marabelle, Christopher R. Flowers, Miriam Mérad, Brian D. Brown, Ranjan Upadhyay, Linda Hammerich, Henry C. Marsh and Suchit Jhunjhunwala. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer Discovery, Journal for ImmunoTherapy of Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.